A first in human evaluation of a novel contrast media saving device-Reference-Cited by-同舟云学术

A first in human evaluation of a novel contrast media saving device

Published:2017-05-04 Issue:6 Volume:90 Page:928-934
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Sapontis James¹,Barron Garry¹,Seneviratne Sujith¹,Fuernau Georg²³^ORCID,Eitel Ingo²³,Ledwoch Jakob²³^ORCID,Thiele Holger²³,Saad Mohammed²³,de Waha Suzanne²³,Poess Janine²³,Desch Steffen²³

Affiliation:

1. Monash Cardiovascular Research Centre, MonashHeart, Monash Health & Department of Medicine (SCS at Monash); Monash University; Melbourne Australia

2. University Heart Centre Lübeck, Department of Cardiology; Angiology, and Intensive Care Medicine, University Hospital Schleswig-Holstein; Lübeck Germany

3. German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck; Lübeck Germany

Funder

Osprey Medical, Inc. Minneapolis, MN

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ccd.27033/fullpdf

Reference19 articles.

1. Epidemiology and prognostic implications of contrast-induced nephropathy;McCullough;Am J Cardiol,2006

2. Economic burden of contrast-induced nephropathy: implications for prevention strategies;Subramanian;J Med Econ,2007

3. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: Insights from the NCDR cath-PCI registry;Tsai;JACC Cardiovasc Interv,2014

4. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation;Mehran;J Am Coll Cardiol,2004

5. Contrast-induced acute kidney injury;McCullough;J Am Coll Cardiol,2016

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost‐effectiveness analysis of dyevert™ Power XT in patients with chronic kidney disease undergoing percutaneous coronary intervention procedures in Spain;Catheterization and Cardiovascular Interventions;2023-06-10

2. A novel angiographic method to estimate arterial blood flow rates using contrast reflux: Effect of injection parameters;Medical Physics;2022-09-09

3. DyeVert Contrast Reduction System Use in Patients Undergoing Coronary and/or Peripheral Angiography: A Systematic Literature Review and Meta-Analysis;Frontiers in Medicine;2022-04-25

4. A Feasibility Study of the DyeVert™ Plus Contrast Reduction System to Reduce Contrast Media Volumes in Percutaneous Coronary Procedures Using Optical Coherence Tomography;Cardiovascular Revascularization Medicine;2021-09

5. New DyeVert system for contrast media volume reduction in percutaneous procedures: “Make kidney safe again”;Catheterization and Cardiovascular Interventions;2021-07